COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics SA : Publie son rapport d'activité du T1 2017

24/08/2017 - 07:00

Bone Therapeutics publiera ses résultats semestriels, le 31 août 2017 Gosselies, Belgique, le 24 août 2017, 7h00 CET - BONE THERAPEUTICS (Euronext Bruxelles et Paris: BOTHE), société de thérapie cellulaire osseuse qui [...]

EDAP TMS Reports Record Second Quarter and First Half 2017 Results

23/08/2017 - 22:01

EDAP-TMS Reports Record Second Quarter and First Half 2017 Results Revenue increased 13.7% to a record €9.3 million for the second quarter of 2017 compared to €8.2 million in 2016 HIFU revenue grew 25% when compared to [...]

Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress

23/08/2017 - 18:31

Oslo, Norway, 23 August 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target treatment-resistant solid tumors, today announces [...]

IBA SA : INFORMATIONS EN MATIERE DE TRANSPARENCE

23/08/2017 - 18:00

IBA - INFORMATIONS EN MATIERE DE TRANSPARENCE Titre II de la loi du 2 mai 2007 et Arrêté Royal du 14 février 2008 Louvain-la-Neuve, Belgique, 23 août 2017 - IBA (Ion Beam Applications SA), le premier fournisseur mondial [...]

IBA SA : DATA CONCERNING TRANSPARENCY

23/08/2017 - 18:00

IBA - DATA CONCERNING TRANSPARENCY Heading II of the law of May 2, 2007 and the Royal Decree of February 14, 2008 Louvain-la-Neuve, Belgium, August 23, 2017 - IBA (Ion Beam Applications SA), the world's leading provider [...]

Novavax' Preclinical Influenza Nanoparticle Study Published in Vaccine

23/08/2017 - 13:00

Novel vaccine candidate, NanoFlu(TM), outperforms market-leading Fluzone® High Dose based on antibody titers and neutralization of recent and historic influenza viruses in a preclinical study GAITHERSBURG, Md., Aug. 23 [...]

Alligator Bioscience AB: Interim report January - June 2017

23/08/2017 - 13:00

Alligator Bioscience AB ( (Nasdaq Stockholm; ATORX ) Interim report January - June 2017 "We have advanced our project pipeline significantly during the second quarter. The immuno-oncology antibody ATOR-1017 moved into [...]

Shire plc : Director/PDMR Shareholding

23/08/2017 - 13:00

Director/PDMR Shareholding August 23, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Crown Bioscience Names Dr. Leon Hall Vice President of Global Scientific Excellence

23/08/2017 - 12:29

SANTA CLARA, Calif., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company [...]

Crown Bioscience nomme le Dr Leon Hall Vice-président de Global Scientific Excellence

23/08/2017 - 12:29

SANTA CLARA, Californie, le 1 er juin, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , une filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et une société mondiale spécialisée [...]

Acarix presents new frontline CAD test at European Society of Cardiology Congress, Barcelona, August 26-30.

23/08/2017 - 10:00

Press release Malmö, August 23, 2017 Acarix presents new frontline CAD test at European Society of Cardiology Congress, Barcelona, August 26-30. Advanced acoustic technology detects partial obstruction of coronary [...]

FIT Biotech Oy: FIT Biotech Board elected Erkki Pekkarinen to the Deputy Chairman of the Board

23/08/2017 - 08:30

FIT Biotech Oy Company release 23.8.2017 at 9.30 EET FIT Biotech Board elected Erkki Pekkarinen to the Deputy Chairman of the Board FIT Biotech Oys' Board of Directors elected in its meeting 22.8.2017 Board member Erkki [...]

Ambu A/S: Interim Report Q3 2016/17

23/08/2017 - 08:06

Ambu raises its outlook for the year after a quarter with growth of 16%, an EBIT margin of 21.6% and free cash flows of DKK 99m. "In Q3, we again saw a steady increase in growth and a solid increase in earnings, with [...]

PCI Biotech appoints Dr Hans Olivecrona as Chief Medical Officer

23/08/2017 - 08:00

Oslo (Norway), 23 August 2017 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company is pleased to announce the appointment of Dr. Hans Olivecrona MD PhD as Chief Medical Officer (CMO). Dr Olivecrona will [...]

Saniona AB: Saniona publishes its interim report for the second quarter 2017

23/08/2017 - 08:00

PRESS RELEASE 23 August 2017 Financial highlights H1 2017 (H1 2016) · Net revenues were SEK 11.9 M (18.9 M) · EBIT was SEK -25.4 M (-14.6 M) · Earnings per share were SEK -1.00 (-0.61) · Diluted earnings per share were [...]

Agfa-Gevaert publishes its second quarter 2017 results - Regulated information - August 23, 2017 - 7:45 a.m. CET

23/08/2017 - 07:45

· Good top line performance of most of the growth engines · Top line impacted by the reorganization of the hardcopy distribution channels in China · Net profit of 27 million Euro · Net financial debt of 27 million Euro [...]

Agfa-Gevaert : Agfa announces a study aiming at focused growth

23/08/2017 - 07:45

Mortsel, Belgium - August 23, 2017 - 7.45 a.m. CET Agfa-Gevaert NV (Agfa) today announced that the Board of Directors has asked the Management to study how to organise the HealthCare IT activities into a stand-alone [...]

Photocure ASA: Results for second quarter and first half year of 2017

23/08/2017 - 07:12

Oslo, Norway, 23 August 2017: Photocure ASA (OSE:PHO), today reported a Hexvix/Cysview revenue growth of 10% to NOK 37.6 million in the second quarter of 2017 (Q2 2016: NOK 34.2), with an EBITDA of NOK 4.7 million for [...]

argenx announces publication in Nature Medicine of preclinical data supporting the therapeutic potential of SIMPLE AntibodyTM ARGX-116 for the treatment of dyslipidemia

23/08/2017 - 07:00

-anti-ApoC3 antibody developed as part of research collaboration with Staten Biotechnology- - Stems from argenx's Innovative Access Program- August 23, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext [...]